PfizerCapital Flow

$Open the interactive terminal to run `audit capital-flow` with custom options.
Capital FlowReturnsEarning QualityDebt DisciplineMoat
CAPITAL FLOW

TICKER: [US.PFE - Pfizer]
PERIOD: [2010-ANNUAL ~ 2025-ANNUAL]


[+] CapEx Intensity: 13.2% (< 20% = light, 20-50% = moderate, > 50% = heavy)
[~] Payout Sustainability: 0.87x (< 0.5 = sustainable, 0.5-1.0 = tight, > 1.0 = unsustainable)


Metric             Value
------------------------
OCF Total        268.70B
FCF Total        233.33B
FCF Conversion     86.8%
CapEx Intensity    13.2%
Payout / FCF       0.87x


           CapEx  [███░░░░░░░░░░░░░░░░░]  13% (35.37B)
Net Acquisitions  [███████░░░░░░░░░░░░░]  36% (97.29B)
        Buybacks  [██████░░░░░░░░░░░░░░]  29% (78.74B)
       Dividends  [█████████░░░░░░░░░░░]  46% (124.66B)


Period          OCF   CapEx       M&A  Buyback/Issuance  Dividends     FCF
--------------------------------------------------------------------------
2010 ANNUAL  11.45B  -1.51B  -273.00M            -1.00B     -6.09B   9.94B
2011 ANNUAL  20.24B  -1.88B  -906.00M            -9.00B     -6.23B  18.36B
2012 ANNUAL  16.75B  -1.42B    10.80B            -8.23B     -6.53B  15.33B
2013 ANNUAL  17.68B  -1.47B   -15.00M           -16.29B     -6.58B  16.22B
2014 ANNUAL  17.08B  -1.58B  -195.00M            -5.00B     -6.61B  15.50B
2015 ANNUAL  14.69B  -1.50B   -16.47B            -6.16B     -6.94B  13.19B
2016 ANNUAL  16.19B  -2.00B   -18.37B            -5.00B     -7.32B  14.19B
2017 ANNUAL  16.80B  -2.22B    -1.00B            -5.00B     -7.66B  14.59B
2018 ANNUAL  15.83B  -2.14B         -           -12.20B     -7.98B  13.69B
2019 ANNUAL  12.59B  -2.05B   -10.86B            -8.87B     -8.04B  10.54B
2020 ANNUAL  14.40B  -2.23B         -                 -     -8.44B  12.18B
2021 ANNUAL  32.58B  -2.71B         -                 -     -8.73B  29.87B
2022 ANNUAL  29.27B  -3.24B   -23.00B            -2.00B     -8.98B  26.03B
2023 ANNUAL   8.70B  -3.91B   -43.43B                 -     -9.25B   4.79B
2024 ANNUAL  12.74B  -2.91B     7.04B                 -     -9.51B   9.84B
2025 ANNUAL  11.70B  -2.63B  -616.00M                 -     -9.77B   9.07B
audit capital-flow
CAPITAL FLOW TICKER: [US.PFE - Pfizer] PERIOD: [2010-ANNUAL ~ 2025-ANNUAL]
[+] CapEx Intensity: 13.2% (< 20% = light, 20-50% = moderate, > 50% = heavy)
[~] Payout Sustainability: 0.87x (< 0.5 = sustainable, 0.5-1.0 = tight, > 1.0 = unsustainable)
Metric Value
------------------------
OCF Total 268.70B
FCF Total 233.33B
FCF Conversion 86.8%
CapEx Intensity 13.2%
Payout / FCF 0.87x
CapEx [███░░░░░░░░░░░░░░░░░] 13% (35.37B)
Net Acquisitions [███████░░░░░░░░░░░░░] 36% (97.29B)
Buybacks [██████░░░░░░░░░░░░░░] 29% (78.74B)
Dividends [█████████░░░░░░░░░░░] 46% (124.66B)
Period OCF CapEx M&A Buyback/Issuance Dividends FCF
--------------------------------------------------------------------------
2010 ANNUAL 11.45B -1.51B -273.00M -1.00B -6.09B 9.94B
2011 ANNUAL 20.24B -1.88B -906.00M -9.00B -6.23B 18.36B
2012 ANNUAL 16.75B -1.42B 10.80B -8.23B -6.53B 15.33B
2013 ANNUAL 17.68B -1.47B -15.00M -16.29B -6.58B 16.22B
2014 ANNUAL 17.08B -1.58B -195.00M -5.00B -6.61B 15.50B
2015 ANNUAL 14.69B -1.50B -16.47B -6.16B -6.94B 13.19B
2016 ANNUAL 16.19B -2.00B -18.37B -5.00B -7.32B 14.19B
2017 ANNUAL 16.80B -2.22B -1.00B -5.00B -7.66B 14.59B
2018 ANNUAL 15.83B -2.14B - -12.20B -7.98B 13.69B
2019 ANNUAL 12.59B -2.05B -10.86B -8.87B -8.04B 10.54B
2020 ANNUAL 14.40B -2.23B - - -8.44B 12.18B
2021 ANNUAL 32.58B -2.71B - - -8.73B 29.87B
2022 ANNUAL 29.27B -3.24B -23.00B -2.00B -8.98B 26.03B
2023 ANNUAL 8.70B -3.91B -43.43B - -9.25B 4.79B
2024 ANNUAL 12.74B -2.91B 7.04B - -9.51B 9.84B
2025 ANNUAL 11.70B -2.63B -616.00M - -9.77B 9.07B